End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8925 USD | -2.25% | +6.25% | -96.71% |
Apr. 19 | Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product | MT |
Apr. 19 | Top Premarket Decliners | MT |
Chart calendar Sunshine Biopharma, Inc.
Upcoming events on Sunshine Biopharma, Inc.
Past events on Sunshine Biopharma, Inc.
2024-05-07 | Q1 2024 Earnings Release (Projected) |
2024-04-01 03:47 pm | Q4 2023 Earnings Release |
2023-12-07 10:00 am | Annual General Meeting |
2023-11-13 08:30 am | Q3 2023 Earnings Release |
2023-10-12 10:00 am | Special Meeting of Warrant Holders |
2023-08-14 02:24 pm | Q2 2023 Earnings Release |
2023-05-10 06:28 pm | Q1 2023 Earnings Release |
2023-04-05 08:00 am | Q4 2022 Earnings Release |
2022-11-07 02:48 pm | Q3 2022 Earnings Release |
2022-08-03 05:24 pm | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 24,1 22,5 7.02% | 44,4 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -4,79 -4,80 0.36% | -0,24 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -4,11 -4,00 -2.89% | 0,84 |
Net income Million USD | Released Forecast Spread | -26,7 | -4,51 -4,21 -7.02% | 0,68 |
EPS USD | Released Forecast Spread | -176 | -19,0 -16,0 -18.75% | 0,77 |
Announcement Date | 04/04/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 5,56 5,00 11.22% | 5,96 6,00 -0.71% | 7,68 6,10 25.9% | 7,00 | 9,00 | 12,6 | 15,8 |
EBIT Million USD | Released Forecast Spread | -0,99 -2,14 53.68% | -0,78 -2,05 62.01% | -1,19 -1,20 1.42% | -1,29 | -0,61 | 0,30 | 1,37 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,81 -1,87 56.37% | -0,61 -1,73 64.75% | -1,03 -0,91 -12.63% | -1,01 | -0,34 | 0,57 | 1,63 |
Net income Million USD | Released Forecast Spread | -0,90 -1,87 51.67% | -0,65 -1,75 62.81% | -1,25 -0,95 -30.99% | -1,05 | -0,38 | 0,53 | 1,59 |
EPS USD | Released Forecast Spread | -2,00 -8,00 75% | -4,00 -6,00 33.33% | -5,70 -3,00 -90% | -1,04 | -0,37 | 0,45 | 1,34 |
Announcement Date | 10/08/23 | 13/11/23 | 28/03/24 | - | - | - | - |
Past sector events for Sunshine Biopharma, Inc.
2024-05-10 11:01 am | PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-10 06:50 am | ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-10 06:46 am | NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-09 | NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release |
2024-05-09 | KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-05-09 | JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release |
2024-05-09 | TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:02 pm | COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release |
2024-05-09 09:58 am | SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release |
2024-05-09 09:06 am | ABBOTT INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SBFM Stock
- Calendar Sunshine Biopharma, Inc.